| Autor: |
Slevin ML, Harvey VJ, Osborne RJ, Shepherd JH, Williams CJ, Mead GM |
| Jazyk: |
angličtina |
| Zdroj: |
European journal of cancer & clinical oncology [Eur J Cancer Clin Oncol] 1986 Mar; Vol. 22 (3), pp. 309-12. |
| DOI: |
10.1016/0277-5379(86)90396-2 |
| Abstrakt: |
A phase II study of tamoxifen was conducted in 22 patients with stage III and IV ovarian cancer who had failed chemotherapy and who had evaluable disease. Tamoxifen was administered at a dose of 20 mg twice daily continuously until evidence of progression. Twenty-one patients had progression of disease within 3 months and one patient had stable disease for 6 months. There were no objective responses to this treatment. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
